NY Laser and Skin Care
New York, 10028, United States
NCT Number: NCT02110134
The purpose of this study is to compare a hydroquinone skin care regimen alone to a combination of Revlite Laser treatment with a hydroquinone skin care regimen for the treatment of melasma.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10028, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Revlite Laser System with hydroquinone skin care regimen for the Treatment of Melasma
Hydroquinone skin care regimen for the Treatment of Melasma
Time frame: From study baseline to completion, approximately 1 year. However, adverse events not resolved by then will be followed up with until they are resolved.
Adverse events were collected and reported to test the safety and efficacy of the device.
Time frame: 1 month post last treatment
Physician and subject satisfaction will be ranked on a scale from 1 to 5, where 1 is extremely dissatisfied and 6 is extremely satisfied.
Time frame: 1 month post last treatment
Photos will be a taken at baseline and post treatment and then improvement assessed using the Global Aesthetic Improvement Scale. This scale ranges from 0 to 3, where 0 is 0-25% clearance from baseline photograph, 1 is 25-50% clearance from baseline photograph, 2 is 50-75% clearance from baseline photograph, and 3 is 75-100% clearance from baseline photograph.
Cynosure, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07727954
Hyperpigmentation, Melanosis
Tijuana, Estado de Baja California, Mexico
View Trial DetailsNCT07676994
Hyperpigmentation, Melanosis
Lahore, Pakistan
View Trial DetailsNCT07644871
Dark Spots, Hyperpigmentation
Irving, Texas, United States
View Trial DetailsNCT03877445
Hyperpigmentation, Melanosis
Nice, France
View Trial Details